Foxp3+ regulatory T cells
Altered Frequencies of CD4+ CD25+ Foxp3+ and CD8+ CD25+ Foxp3+ Regulatory T Cells in Pre-eclampsia
8
Low dose temozolomide before dendritic cell vaccination reduces (specifically) CD4+CD25++Foxp3+ regulatory T cells in advanced melanoma patients
10
Deletion of Foxp3+ regulatory T cells in genetically targeted mice supports development of intestinal inflammation
11
CD39+Foxp3+ regulatory T Cells suppress pathogenic Th17 cells and are impaired in multiple sclerosis
28
Harnessing FOXP3+ regulatory T cells for transplantation tolerance
8
Original Article The immune response is a prerequisite for the development of CD4 Foxp3 regulatory T cells in transplantation
9
CD4+CD25+FOXP3+ Regulatory T Cells In Allogeneic Hematopoietic Cell Transplantation
8
Langerhans cells protect from allergic contact dermatitis in mice by tolerizing CD8+ T cells and activating Foxp3+ regulatory T cells
13
The frequency of CD25+CD4+ and FOXP3+ regulatory T cells in ectopic endometrium and ectopic decidua
7
Original Article Immunohistochemical distribution of FOXP3+ regulatory T cells in colorectal cancer patients
14
Review Article Advances in distinguishing natural from induced Foxp3 regulatory T cells
8
Sodium chloride inhibits the suppressive function of FOXP3+ regulatory T cells
12
Depletion of FOXP3+ regulatory T cells promotes hypercholesterolemia and atherosclerosis
13
Intrinsic predisposition of naïve cystic fibrosis T cells to differentiate towards a Th17 phenotype
8
Effects of conventional immunosuppressive treatment on CD244+ (CD28null) and FOXP3+ T cells in the inflamed muscle of patients with polymyositis and dermatomyositis
14
Human in vitro induced T regulatory cells and memory T cells share common demethylation of specific FOXP3 promoter region
5
Tumour draining axillary lymph nodes in patients with large and locally advanced breast cancers undergoing neoadjuvant chemotherapy (NAC): the crucial contribution of immune cells (effector, regulatory) and cytokines (TH1, TH2) to immune mediated tumour cell death induced by NAC
14
Abnormal T regulatory cells (Tregs: FOXP3+, CTLA 4+), myeloid derived suppressor cells (MDSCs: monocytic, granulocytic) and polarised T helper cell profiles (Th1, Th2, Th17) in women with large and locally advanced breast cancers undergoing neoadjuvant chemotherapy (NAC) and surgery: failure of abolition of abnormal treg profile with treatment and correlation of treg levels with pathological response to NAC
16
Regulation of Foxp3+ inducible regulatory T cell stability by SOCS2
11
Wilms’ tumor susceptibility: possible involvement of FOXP3 and CXCL12 genes
8